All material subject to strictly enforced copyright laws. © 2021 Euromoney Institutional Investor PLC group
EquityEquity IPOs

Huvepharma pulls €463m IPO

Amsterdam_stock_exchange_2_alamy_575_375

Bulgarian animal healthcare company Huvepharma has become the latest casualty in an IPO market oversaturated with supply.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree